Related Experiment Videos

Rationale for the use of very-low-dose combinations as first-line treatment of hypertension

B Waeber1, H R Brunner

  • 1Division of Clinical Pathophysiology and Medical Teaching, Department of Medicine, University Hospital, Lausanne, Switzerland. bwaeber@chuv.hospvd.ch

Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|February 19, 2002
PubMed

Insights

Managing hypertension is challenging, often requiring multiple medications. Fixed-dose combinations, especially very-low-dose ones, offer improved efficacy and tolerability for blood pressure control.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Hypertension management is complex, with many patients needing multiple antihypertensive drugs.
  • Achieving target blood pressure (<140/90 mmHg) frequently necessitates combination therapy.
  • Fixed-dose combinations are gaining popularity due to convenience and potential efficacy.

Purpose of the Study:

  • To evaluate the role and benefits of fixed-dose combinations in hypertension management.
  • To highlight the advantages of very-low-dose drug combinations for efficacy and tolerability.

Main Methods:

  • Review of current therapeutic strategies for hypertension.
  • Analysis of the pharmacological principles behind drug combinations.
  • Assessment of the clinical profile of very-low-dose fixed-dose combinations.

Main Results:

  • Combination therapy is often required to reach blood pressure goals.
  • Fixed-dose combinations maximize antihypertensive efficacy by targeting different mechanisms.
  • Very-low-dose combinations offer significant efficacy with minimal dose-dependent side effects.

Conclusions:

  • Fixed-dose combinations are increasingly important in hypertension treatment.
  • Very-low-dose combinations present a promising option for initiating treatment.
  • These combinations offer a favorable balance of efficacy and tolerability.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...